A molecular switch between mammalian MLL complexes dictates response to Menin–MLL inhibition

YM Soto-Feliciano, FJ Sánchez-Rivera, F Perner… - Cancer discovery, 2023 - AACR
Menin interacts with oncogenic MLL1-fusion proteins, and small molecules that disrupt these
associations are in clinical trials for leukemia treatment. By integrating chromatin-focused …
被引用次数：15 相关文章
[PDF] aacrjournals.org

[PDF][PDF] A Molecular Switch between Mammalian MLL Complexes Dictates Response to Menin–MLL Inhibition

YM Soto-Feliciano, FJ Sánchez-Rivera, F Perner… - Cancer Discovery, 2023 - AACR
Menin interacts with oncogenic MLL1-fusion proteins, and small molecules that disrupt these
associations are in clinical trials for leukemia treatment. By integrating chromatin-focused …

A Molecular Switch between Mammalian MLL Complexes Dictates Response to Menin–MLL Inhibition

YM Soto-Feliciano… - Cancer …, 2023 - mdanderson.elsevierpure.com
Menin interacts with oncogenic MLL1-fusion proteins, and small molecules that disrupt these
associations are in clinical trials for leukemia treatment. By integrat ing chromatin-focused …

A Molecular Switch between Mammalian MLL Complexes Dictates Response to Menin-MLL Inhibition

YM Soto-Feliciano, FJ Sánchez-Rivera… - Cancer …, 2023 - repository.cshl.edu
UNLABELLED: Menin interacts with oncogenic MLL1-fusion proteins, and small molecules
that disrupt these associations are in clinical trials for leukemia treatment. By integrating …

A molecular switch between mammalian MLL complexes dictates response to Menin-MLL inhibition.

YM Soto-Feliciano, FJ Sanchez-Rivera, F Perner… - Cancer …, 2022 - europepmc.org
Menin interacts with oncogenic MLL1-fusion proteins, and small molecules that disrupt these
associations are in clinical trials for leukemia treatment. By integrating chromatin-focused …

A Molecular Switch between Mammalian MLL Complexes Dictates Response to Menin-MLL Inhibition

YM Soto-Feliciano, FJ Sánchez-Rivera… - Cancer …, 2023 - pubmed.ncbi.nlm.nih.gov
Menin interacts with oncogenic MLL1-fusion proteins, and small molecules that disrupt these
associations are in clinical trials for leukemia treatment. By integrating chromatin-focused …

Molecular switch between mammalian MLL complexes dictates response to Menin-MLL inhibition

YM Soto-Feliciano, FJ Sánchez-Rivera, F Perner… - bioRxiv, 2021 - biorxiv.org
The chromatin adaptor Menin interacts with oncogenic fusion proteins encoded by MLL1-
rearrangements (MLL1-r), and small molecules that disrupt these associations are currently …
[HTML] nih.gov

[HTML][HTML] A Molecular Switch between Mammalian MLL Complexes Dictates Response to Menin–MLL Inhibition

YM Soto-Feliciano, FJ Sánchez-Rivera, F Perner… - Cancer …, 2023 - ncbi.nlm.nih.gov
Menin interacts with oncogenic MLL1-fusion proteins, and small molecules that disrupt these
associations are in clinical trials for leukemia treatment. By integrating chromatin-focused …
[HTML] nih.gov

[HTML][HTML] A molecular switch between mammalian MLL complexes dictates response to Menin-MLL inhibition

YM Soto-Feliciano, FJ Sánchez-Rivera, F Perner… - Cancer …, 2023 - ncbi.nlm.nih.gov
Menin interacts with oncogenic MLL1-fusion proteins, and small molecules that disrupt these
associations are in clinical trials for leukemia treatment. By integrating chromatin-focused …

A molecular switch between mammalian MLL complexes dictates response to Menin-MLL inhibition

YM Soto-Feliciano, FJ Sánchez-Rivera, F Perner… - 2021 - europepmc.org
The chromatin adaptor Menin interacts with oncogenic fusion proteins encoded by MLL1-
rearrangements (MLL1-r), and small molecules that disrupt these associations are currently …